Aringhieri S - Search Results

1

Is Adult Hippocampal Neurogenesis Really Relevant for the Treatment of Psychiatric Disorders?

Carli M, Aringhieri S, Kolachalam S, Longoni B, Grenno G, Rossi M, Gemignani A, Fornai F, Maggio R, Scarselli M. Carli M, et al. Among authors: aringhieri s. Curr Neuropharmacol. 2021;19(10):1640-1660. doi: 10.2174/1570159X18666200818194948. Curr Neuropharmacol. 2021. PMID: 32811415 Free PMC article. Review.

2

Revealing G-protein-coupled receptor oligomerization at the single-molecule level through a nanoscopic lens: methods, dynamics and biological function.

Scarselli M, Annibale P, McCormick PJ, Kolachalam S, Aringhieri S, Radenovic A, Corsini GU, Maggio R. Scarselli M, et al. Among authors: aringhieri s. FEBS J. 2016 Apr;283(7):1197-217. doi: 10.1111/febs.13577. Epub 2015 Nov 28. FEBS J. 2016. PMID: 26509747 Free article. Review.

3

Clozapine as the most efficacious antipsychotic for activating ERK 1/2 kinases: Role of 5-HT_2A receptor agonism.

Aringhieri S, Kolachalam S, Gerace C, Carli M, Verdesca V, Brunacci MG, Rossi C, Ippolito C, Solini A, Corsini GU, Scarselli M. Aringhieri S, et al. Eur Neuropsychopharmacol. 2017 Apr;27(4):383-398. doi: 10.1016/j.euroneuro.2017.02.005. Epub 2017 Mar 7. Eur Neuropsychopharmacol. 2017. PMID: 28283227

4

Dopamine D2 Receptors Dimers: How can we Pharmacologically Target Them?

Carli M, Kolachalam S, Aringhieri S, Rossi M, Giovannini L, Maggio R, Scarselli M. Carli M, et al. Among authors: aringhieri s. Curr Neuropharmacol. 2018 Jan 30;16(2):222-230. doi: 10.2174/1570159X15666170518151127. Curr Neuropharmacol. 2018. PMID: 28521704 Free PMC article. Review.

5

Molecular targets of atypical antipsychotics: From mechanism of action to clinical differences.

Aringhieri S, Carli M, Kolachalam S, Verdesca V, Cini E, Rossi M, McCormick PJ, Corsini GU, Maggio R, Scarselli M. Aringhieri S, et al. Pharmacol Ther. 2018 Dec;192:20-41. doi: 10.1016/j.pharmthera.2018.06.012. Epub 2018 Jun 25. Pharmacol Ther. 2018. PMID: 29953902 Review.

6

Atypical Antipsychotics and Metabolic Syndrome: From Molecular Mechanisms to Clinical Differences.

Carli M, Kolachalam S, Longoni B, Pintaudi A, Baldini M, Aringhieri S, Fasciani I, Annibale P, Maggio R, Scarselli M. Carli M, et al. Among authors: aringhieri s. Pharmaceuticals (Basel). 2021 Mar 8;14(3):238. doi: 10.3390/ph14030238. Pharmaceuticals (Basel). 2021. PMID: 33800403 Free PMC article. Review.

7

Melanocortin receptor 4 as a new target in melanoma therapy: Anticancer activity of the inhibitor ML00253764 alone and in association with B-raf inhibitor vemurafenib.

Orlandi P, Banchi M, Vaglini F, Carli M, Aringhieri S, Bandini A, Pardini C, Viaggi C, Lai M, Alì G, Ottani A, Vandini E, Guidi P, Bernardeschi M, La Rocca V, Francia G, Fontanini G, Pistello M, Frenzilli G, Giuliani D, Scarselli M, Bocci G. Orlandi P, et al. Among authors: aringhieri s. Biochem Pharmacol. 2024 Jan;219:115952. doi: 10.1016/j.bcp.2023.115952. Epub 2023 Nov 29. Biochem Pharmacol. 2024. PMID: 38036189 Free article.

8

The C-terminus of the prototypical M2 muscarinic receptor localizes to the mitochondria and regulates cell respiration under stress conditions.

Fasciani I, Petragnano F, Wang Z, Edwards R, Telugu N, Pietrantoni I, Zabel U, Zauber H, Grieben M, Terzenidou ME, Di Gregorio J, Pellegrini C, Santini S Jr, Taddei AR, Pohl B, Aringhieri S, Carli M, Aloisi G, Marampon F, Charlesworth E, Roman A, Diecke S, Flati V, Giorgi F, Amicarelli F, Tobin AB, Scarselli M, Tokatlidis K, Rossi M, Lohse MJ, Annibale P, Maggio R. Fasciani I, et al. Among authors: aringhieri s. PLoS Biol. 2024 Apr 29;22(4):e3002582. doi: 10.1371/journal.pbio.3002582. Online ahead of print. PLoS Biol. 2024. PMID: 38683874

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8 results

Search Page